B.S. Kappelhoff

Latest

• Pharmacokinetics of nevirapine: once-daily versus twice-daily dosing in the 2NN study
• Are adverse events of nevirapine and efavirenz related to plasma concentrations?
• Nevirapine and efavirenz pharmacokinetics and covariate analysis in the 2NN study